Category : Tell us your Story | Sub Category : Tell us your Story Posted on 2026-03-12 10:58:45
In early March 2026, the Federal Executive Council (FEC) of Nigeria approved ₦9.99 billion (about $7.2 million) in funding to strengthen cancer treatment infrastructure across the country, while also ensuring continued free antiretroviral (ARV) therapy for people living with HIV/AIDS. This move comes as part of broader efforts to boost healthcare delivery and expand access to critical services nationwide.
At a council meeting presided over by President Bola Ahmed Tinubu, two major health interventions were approved:
1. Continued Free HIV Treatment
Part of the funding was allocated to procure antiretroviral drugs to sustain Nigeria’s long‑standing free HIV treatment programme. The approval addresses earlier concerns that drug stockouts could disrupt treatment for millions of Nigerians living with HIV. The contract was awarded to a Nigerian pharmaceutical company in partnership with an international brand, with the goal of gradually building local production capacity for ARVs.
2. Upgrade of Cancer Treatment Infrastructure
The other portion of the approved funds is dedicated to upgrading cancer treatment facilities in six cancer centres — one in each of Nigeria’s geopolitical zones. These upgrades focus particularly on:
Replacing and upgrading radiotherapy equipment, a vital part of cancer treatment
Training healthcare personnel in oncology and radiotherapy practices
Improving overall treatment capacity so that more patients can receive care without having to travel abroad for advanced therapy
Radiotherapy is a cornerstone of cancer care, especially for cancers like breast, prostate, and cervical cancers. But in Nigeria, outdated equipment and gaps in skilled staffing have historically limited access to high‑quality radiation treatment. The new funding aims to change that by ensuring that each geopolitical zone has at least one centre with improved radiotherapy capacity.
Broader access to cancer care: Nigeria has only a limited number of functional radiotherapy machines, and waiting lists for treatment can be long. Strengthening equipment and training across the country can reduce travel and cost barriers for patients.
Equity across regions: By targeting one centre per geopolitical zone, the government is addressing regional imbalances in cancer treatment access. Patients no longer have to travel vast distances for essential therapy.
Healthcare system strengthening: Investing in both infrastructure and personnel training means building long‑term capacity, not just short‑term fixes. Skilled oncology staff are crucial for quality diagnosis, treatment delivery, and improved outcomes.
Experts have repeatedly pointed out that Nigeria’s limited cancer treatment infrastructure contributes to poorer outcomes compared to high‑income countries. For example, there are only a handful of radiotherapy centres nationally, and many hospitals struggle with outdated machines or lack of trained specialists. Expanding this capacity is widely seen as a key step in strengthening the country’s response to cancer.
Alongside the investment in cancer infrastructure, the government also emphasized the importance of maintaining free HIV treatment as a public health priority. HIV/AIDS programmes have significantly expanded over the past decade, and sustaining drug availability is critical to preserving lives and preventing new infections.
By combining support for both communicable and non‑communicable diseases, the Federal Government is signalling a more integrated and balanced approach to Nigeria’s health challenges.